Stoke Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2018 | 727.4K |
| FY2019 | 32.9M |
| FY2020 | 36.6M |
| FY2021 | 36.7M |
| FY2022 | 38.9M |
| FY2023 | 44.0M |
| FY2024 | 54.0M |
| FY2025 | 59.2M |
| FY2026 | 59.2M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2018 | 727.4K |
| FY2019 | 32.9M |
| FY2020 | 36.6M |
| FY2021 | 36.7M |
| FY2022 | 38.9M |
| FY2023 | 44.0M |
| FY2024 | 54.0M |
| FY2025 | 59.2M |
| FY2026 | 59.2M |